IDEXX LABORATORIES, INC.

(IDXX)
  Report
Real-time Estimate Cboe BZX  -  10:20 2022-08-09 am EDT
396.91 USD   -2.48%
09:24aWALL STREET STOCK EXCHANGE : Calm prevails ahead of inflation data
MS
05:25aANALYST RECOMMENDATIONS : Nvidia, Nike, Linde, Republic Services, Idexx Laboratories...
MS
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Idexx: 4Q Earnings Snapshot

01/31/2020 | 06:59am EDT

WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported fourth-quarter earnings of $90.5 million.

On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.04.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 91 cents per share.

The Animal diagnostic and health care company posted revenue of $605.4 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $599.9 million.

For the year, the company reported profit of $427.7 million, or $4.89 per share. Revenue was reported as $2.41 billion.

Idexx expects full-year earnings to be $5.42 to $5.58 per share, with revenue in the range of $2.62 billion to $2.66 billion.

Idexx shares have risen roughly 9% since the beginning of the year. The stock has increased 37% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX

Automated Insights, source Associated Press News

All news about IDEXX LABORATORIES, INC.
09:24aWALL STREET STOCK EXCHANGE : Calm prevails ahead of inflation data
MS
05:25aANALYST RECOMMENDATIONS : Nvidia, Nike, Linde, Republic Services, Idexx Laboratories...
MS
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates ..
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overw..
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Over..
MT
08/03Atlantic Equities Adjusts Price Target on IDEXX Laboratories to $490 From $500, Reitera..
MT
08/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
08/02WALL STREET STOCK EXCHANGE : Pelosi’s expected Taiwan visit spooks markets
MS
08/02SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Tuesday
MT
08/02TRANSCRIPT : IDEXX Laboratories, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 382 M - -
Net income 2022 687 M - -
Net Debt 2022 1 126 M - -
P/E ratio 2022 50,3x
Yield 2022 -
Capitalization 34 191 M 34 191 M -
EV / Sales 2022 10,4x
EV / Sales 2023 9,55x
Nbr of Employees 10 350
Free-Float 77,1%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 407,00 $
Average target price 477,00 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-38.07%34 191
ABBOTT LABORATORIES-22.37%190 883
MEDTRONIC PLC-9.83%124 341
STRYKER CORPORATION-18.73%82 217
BECTON, DICKINSON AND COMPANY4.15%73 001
HOYA CORPORATION-15.34%38 786